Chabaued, M. et al. Arthritis and Rheumatism, 1999, vol. 42, No. 5, pp. 963-970.* |
Arend, W. et al. Arthritis and Rheumatism, 1995, vol. 38, No. 2, pp. 151-160.* |
Aarvak et al., “Analysis of IL-17 and other cytokines and surface markers of RA inflammatory T cell clones,” American College of Rheumatology (ACR) meeting, Poster 1448, Nov. 1997. |
Amin, A. R. et al., “The expression and regulation of nitric oxide synthase in human osteoarthritis-affected chondrocytes: Evidence for up-regulated neuronal nitric oxide synthase,” J. Exp. Med., 182:2097-2102, Dec. 1995. |
Antonysamy, M. et al., “Evidence for a of role IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors,” J. Immunol., 162:577-584, 1999. |
Attur, M. G. et al., “Interleukin-17 up-regulation of nitric oxide production in human osteoarthritis cartilage,” Arthritis& Rheumatism, 40(6):1050-1053, 1997. |
Baragi, V. M. et al., “Transplantation of transduced chondrocytes protects articular cartilage from interleukin 1-induced extracellular matrix degradation,” J. Clin. Invest., 96(5):2454-2460, 1995. |
Caron, J. P. et al., “Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis,” Arthritis & Rheum., 39(9):1535-1544, 1996. |
Chabaud, M. et al., “Regulation of the effects of IL 17 on IL 6 and LIF production by RA synoviocytes,” American College of Rheumatology (ACR) meeting, Poster 1449, Nov. 1997. |
Chabaud, M. et al., “Human Interluekin-17: A T Cell-Derived Proinflammatory Cytokine Produced by the Rheumatoid Synovium,” Arthritis & Rheumatism, 42(5):963-970, 1999. |
Chabaud, M. et al., “Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis,” Cytokine, 12(7):1092-1099, 2000. |
Chabaud, M. et al., “Enhancing effect of IL-17 on IL-1-Induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by TH2 cytokines,” J. Immunol., 161:409-414, 1998. |
Dudler et al., “In vivo effects of murine recombinant interleukiN-17 on synovial joint in mice,” American College of Rheumatology (ACR) meeting, Poster 1450, Nov. 1997. |
Fossiez et al., “T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines,” J. Exp. Med., 183:2593-2603, 1996. |
Fouilhoux et al., “Production of IL-17 and its regulation in rheumatoid synovium,” American College of Rheumatology (ACR) meeting, Poster 1447, 1997. |
Joosten et al., “IL-1αβ blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-α blockade only ameliorates joint inflammation,” J. Immunol., 163:5049-5055, 1999. |
Jovanovic et al., “Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte/macrophages,” Arthritis Rheum., 43(5):1134-1144, 2000. |
Jovanovic, D. et al., “IL-17 stimulates the production and expression of proinflammatory cytokines, IL-β and TNF-α, by human macrophages,” J. of Immunol., 160:3513-3521, 1998. |
Jovanovic, D. et al., “IL-17 stimulates the secretion of proinflammatory cytokines by human macrphages,” American College of Rheumatology (ACR) meeting, Poster 1446, Nov. 1997. |
Kotake, S., “IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis,” J. Clin. Invest., 103(9):1345-1352, 1999. |
Lotz et al., IL-17 promotes cartilage degradation, Arthritis and Rheumatism, 39 supp.(9):S120, No. 559, 1996. |
Spriggs, M. K., “Interleukin-17 and its receptor,” J. Clin. Immunol., 17(5):366-369, 1997. |
Yao, Z. et al., “Molecular characterization of the human inteleukin (IL)-17 receptor,” Cytokine, 9(11):794-800, 1997. |
Yao et al., “Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor,” Immunity 3:811-821, 1995. |
Yao et al., “Complete nucleotide sequence of the mouse CTLA8 gene,” Gene, 168:223-225 1996. |
Yao et al., “Human IL-17: A novel cytokine derived from T cells,” J. Immunol., 1555483-5486, 1995. |